ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Grifols SA

Grifols SA (GRFS)

7,085
0,005
(0,07%)
Fermé 02 Juillet 10:00PM
7,085
0,00
(0,00%)
Après les heures de négociation: 1:55AM

Grifols SA (GRFS) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
7,085
( 0,07% )
Prix Achat
7,00
Prix Vente
7,50
Volume échangé
1 100 766
6,96 Fourchette du Jour 7,16
7,055 Plage de 52 semaines 11,14
Cap du marché
Clôture Veille
7,08
Ouverture
7,10
Dernière Transaction
1
@
7.0001
Dernière heure de transaction
Volume financier
US$ 7 741 366
VWAP
7,0327
Volume moyen (3 m)
US$ 2 564 958
Actions en circulation
680 575 312
Rendement du Dividende (LTM)
(3,36%)
Ratio Cours sur Bénéfices
14,97
Bénéfice par action (BPA)
-
Chiffre d'affairess (LTM)
7,44B
Bénéfice net (LTM)
415M

À propos de Grifols SA

Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company... Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testing equipment, reagents, and other equipment, as well as provides transfusion medicine, clinical diagnostics, and testing services. It also offers biological products, including albumin, albumin-derived products, immunoglobulins, thrombin, other proteins, and intermediate plasma products to pharma and biotech companies for biopharma use; and whole blood, blood components, processed plasma, and clinical samples to life-science research and in-vitro diagnostic companies for diagnostic use. In addition, the company provides healthcare solutions for hospitals, such as intravenous solutions to maintain or restore fluids and electrolyte balance in patients; high-tech solutions to automate hospital processes; clinical nutrition to deliver nutrition and medication; and medical devices comprising instrumentation and disposable materials for various hospital services, which include interventional neuroradiology, hemodynamics, urology, anesthesiology and cardiovascular surgery, as well as manufacturing services to third parties and research activities. Further, it is involved in engineering services; packaging, labelling, storage, distribution, manufacturing, and development of pharmaceutical products; import, export, and commercialization activities; travel agency services; reinsurance of insurance policies; support services; law business; and consultation, administration, and financing services. The company was founded in 1909 and is headquartered in Barcelona, Spain. Show more

Secteur
Healthcare
Industrie
Pharmaceuticals
Site Web
Siège social
Barcelona, Spain
Fondé
2026
Grifols SA est coté dans le secteur Healthcare de la NASDAQ avec le ticker GRFS. Le dernier cours de clôture d'Grifols était de US$7,08. Au cours de la dernière année, les actions de Grifols ont été négociées dans une fourchette de prix de US$ 7,055 à US$ 11,14.

Grifols compte actuellement 680 575 312 actions en circulation. La capitalisation boursière d'Grifols est de US$4,82 milliard. Grifols a un ratio cours/bénéfice (ratio PE) de 14.97.

GRFS Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.045-0.6311360448817.137.497.0556757857.23987638DR
4-0.515-6.776315789477.67.737.0556302097.36599525DR
12-1.355-16.05450236978.448.837.0556662847.88340456DR
26-2.327-24.72375690619.4129.777.0556456708.27017693DR
52-1.825-20.48260381598.9111.147.0556968869.04624437DR
156-2.065-22.56830601099.1512.14995.300111107438.20419785DR
260-10.145-58.879860708117.2317.455.300110422328.87072858DR

GRFS - Frequently Asked Questions (FAQ)

What is the current Grifols SA share price?
The current share price of Grifols SA is US$ 7,085
How many Grifols SA shares are in issue?
Grifols SA has 680 575 312 shares in issue
What is the market cap of Grifols SA?
The market capitalisation of Grifols SA is USD 4,82B
What is the 1 year trading range for Grifols SA share price?
Grifols SA has traded in the range of US$ 7,055 to US$ 11,14 during the past year
What is the PE ratio of Grifols SA?
The price to earnings ratio of Grifols SA is 14,97
What is the cash to sales ratio of Grifols SA?
The cash to sales ratio of Grifols SA is 0,75
What is the registered address of Grifols SA?
The registered address for Grifols SA is Parque Empresarial Can Sant Joan, Barcelona, Catalonia, 08174
What is the Grifols SA website address?
The website address for Grifols SA is www.grifols.com
Which industry sector does Grifols SA operate in?
Grifols SA operates in the Pharmaceuticals sector

GRFS Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion